Haemonetics Corporation — Net Income by Fiscal Year
18 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/923c8c59-db1a-4115-ac68-1aab0d67d4e4/serie/net-income
| Fiscal year | Net Income | Period | Evidence |
|---|---|---|---|
| FY 2025 | $97.3k | 2025-03-30 – 2026-03-28 | evidence 0000313143-26-000074 |
| FY 2024 | $167.7M | 2024-03-31 – 2025-03-29 | evidence 0000313143-25-000025 |
| FY 2023 | $117.6M | 2023-04-02 – 2024-03-30 | evidence 0000313143-24-000020 |
| FY 2022 | $115.4M | 2022-04-03 – 2023-04-01 | evidence 0000313143-23-000014 |
| FY 2021 | $43.4M | 2021-04-04 – 2022-04-02 | evidence 0000313143-22-000024 |
| FY 2020 | $79.5M | 2020-03-29 – 2021-04-03 | evidence 0000313143-21-000023 |
| FY 2019 | $76.5M | 2019-03-31 – 2020-03-28 | evidence 0000313143-20-000028 |
| FY 2018 | $55.0M | 2018-04-01 – 2019-03-30 | evidence 0000313143-19-000022 |
| FY 2017 | $45.6M | 2017-04-02 – 2018-03-31 | evidence 0000313143-18-000020 |
| FY 2016 | $-26.3M | 2016-04-03 – 2017-04-01 | evidence 0000313143-17-000017 |
| FY 2015 | $-55.6M | 2015-03-29 – 2016-04-02 | evidence 0000313143-16-000128 |
| FY 2014 | $16.9M | 2014-03-30 – 2015-03-28 | evidence 0000313143-15-000033 |
| FY 2013 | $35.1M | 2013-03-31 – 2014-03-29 | evidence 0000313143-14-000055 |
| FY 2012 | $38.8M | 2012-04-01 – 2013-03-30 | evidence 0000313143-13-000085 |
| FY 2011 | $66.9M | 2011-04-03 – 2012-03-31 | evidence 0000313143-12-000071 |
| FY 2010 | $80.0M | 2010-04-04 – 2011-04-02 | evidence 0000950123-11-054481 |
| FY 2009 | $58.4M | 2009-03-29 – 2010-04-03 | evidence 0000950123-11-054481 |
| FY 2008 | $59.3M | 2008-03-30 – 2009-03-28 | evidence 0000950123-11-054481 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
Haemonetics Corporation — all facts · Revenue · Operating Income